SAN DIEGO--(EON: Enhanced Online News)--Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference. This conference will be held at The Lotte New York Palace in New York City on November 29th and 30th and the presentation will be made available on Pathway.com and Pathway’s social media.
“We believe that proactively sharing healthcare industry knowledge helps us all gain a broader perspective that ultimately allows us to help more patients.”
“Pathway is honored to be a part of this important conference,” said Jim Plante, Founder & CEO. “We believe that proactively sharing healthcare industry knowledge helps us all gain a broader perspective that ultimately allows us to help more patients.”
About Pathway Genomics
Founded in 2008, Pathway Genomics offers digital healthcare and genetic testing. Based in San Diego, CA our CLIA and CAP accredited clinical laboratory provides physicians and their patients in 40+ countries with actionable and accurate precision healthcare information to improve health and wellness. The company’s program with IBM Watson is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.
Pathway believes in the power of “genetics first” to help make proactive, informed decisions about health and lifestyle. Our physician-ordered tests include assays for diet and weight loss, circulating tumor DNA (liquid biopsy), hereditary cancer, pharmacogenomics and carrier screening. For more about Pathway Genomics, visit www.pathway.com and follow us on Facebook, LinkedIn and Twitter.